jrnl7753

Publication Venue For

  • PRDM16 suppresses HIF-targeted gene expression in kidney cancer..  217. 2020
  • Human tau pathology transmits glial tau aggregates in the absence of neuronal tau.  217. 2020
  • Cell circuits between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development.  215:2586-2599. 2018
  • Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection.  215:1823-1838. 2018
  • Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation.  215:1803-1812. 2018
  • Blimp-1-dependent and -independent natural antibody production by B-1 and B-1-derived plasma cells.  214:2777-2794. 2017
  • Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression.  213:2049-2063. 2016
  • Dpy30 is critical for maintaining the identity and function of adult hematopoietic stem cells.  213:2349-2364. 2016
  • IL-6 IL-6 promotes the differentiation of a subset of naive CD8+ T cells into IL-21-producing B helper CD8+ T cells.  213:2281-2291. 2016
  • Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction.  213:1353-1374. 2016
  • RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.  213:209-223. 2016
  • Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection.  212:1405-1414. 2015
  • Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD.  211:1937-1945. 2014
  • Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells.  211:1637-1655. 2014
  • Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.  210:2851-2872. 2013
  • Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.  210:2641-2659. 2013
  • IL-2 coordinates IL-2-producing and regulatory T cell interplay.  210:2707-2720. 2013
  • CD4+ T helper cells use CD154-CD40 interactions to counteract T reg cell- mediated suppression of CD8+ T cell responses to influenza.  210:1591-1601. 2013
  • The link between antibodies to oxldl and natural protection against pneumococci depends on dh gene conservation.  210:875-890. 2013
  • The Ataxia telangiectasia mutated kinase controls Igκ allelic exclusion by inhibiting secondary Vκ-to-Jκ rearrangements.  210:233-239. 2013
  • RAG-induced DNA double-strand breaks signal through Pim2 to promote pre-B cell survival and limit proliferation.  209:11-17. 2012
  • Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated.  208:2237-2249. 2011
  • HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.  208:1367-1376. 2011
  • The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns.  208:1001-1013. 2011
  • Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.  207:1687-1699. 2010
  • Gαq-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity.  207:1775-1789. 2010
  • Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.  207:1609-1616. 2010
  • miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.  207:1589-1597. 2010
  • Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis (The Journal of Experimental Medicine (2010) 207, 6 (1321-1332)).  207:1569. 2010
  • Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis.  207:1321-1332. 2010
  • Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines.  207:763-776. 2010
  • Pulmonary dendritic cells: Thinking globally, acting locally.  207:451-454. 2010
  • CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription.  207:51-59. 2010
  • Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock.  206:2897-2906. 2009
  • Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.  206:2625-2639. 2009
  • Id2-, RORγt-, and LTβR-independent initiation of lymphoid organogenesis in ocular immunity.  206:2351-2364. 2009
  • T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow.  206:2469-2481. 2009
  • IL-9 as a mediator of Th17-driven inflammatory disease.  206:1653-1660. 2009
  • Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.  206:1273-1289. 2009
  • Evolution of HLA-B 5703 hiv-1 escape mutations in HLA-B 5703-positive individuals and their transmission recipients.  206:909-921. 2009
  • MRN complex function in the repair of chromosomal Rag-mediated DNA double-strand breaks.  206:669-679. 2009
  • Contrasting roles for all-trans retinoic acid in TGF-β-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells.  206:343-357. 2009
  • ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo.  205:1227-1242. 2008
  • Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.  205:1009-1017. 2008
  • Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus.  205:711-723. 2008
  • Altered development of the brain after focal herpesvirus infection of the central nervous system.  205:423-435. 2008
  • Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.  205:79-90. 2008
  • Identification of an alternative Gαq-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes.  204:2705-2718. 2007
  • Defects in coding joint formation in vivo in developing ATM-deficient B and T lymphocytes.  204:1371-1381. 2007
  • Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism.  204:605-618. 2007
  • Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help.  203:1985-1998. 2006
  • Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection.  203:1805-1815. 2006
  • Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production.  203:1567-1578. 2006
  • Regulation of osteoclast function and bone mass by RAGE.  203:1067-1080. 2006
  • Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo.  203:203-213. 2006
  • Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity.  202:1319-1325. 2005
  • Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells.  202:783-791. 2005
  • Antigenic conservation and immunogenicity of the HIV coreceptor binding site.  201:1407-1419. 2005
  • Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen.  201:845-851. 2005
  • Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses.  200:1613-1622. 2004
  • Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.  200:1243-1256. 2004
  • Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein.  199:753-761. 2004
  • Alveolar Macrophage-mediated Killing of Pneumocystis carinii f. sp. muris Involves Molecular Recognition by the Dectin-1 β-Glucan Receptor.  198:1677-1688. 2003
  • CD40-deficient, Influenza-specific CD8 Memory T Cells Develop and Function Normally in a CD40-sufficient Environment.  198:1759-1764. 2003
  • Restricted clonal expression of IL-2 by naive T cells reflects differential dynamic interactions with dendritic cells.  198:123-132. 2003
  • Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation.  197:751-762. 2003
  • The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: Reciprocal regulation by interleukin (IL)-4 and IL-12.  196:693-704. 2002
  • T cell costimulation through CD28 depends on induction of the Bcl-xγ isoform: Analysis of Bcl-xγ-deficient mice.  196:87-95. 2002
  • Harnessing a neural-immune circuit to control inflammation and shock.  195. 2002
  • Restrictions limiting the generation of DNA double strand breaks during chromosomal V(D)J recombination.  195:309-316. 2002
  • T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis.  195:71-84. 2002
  • Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in Iga nephropathy.  194:417-425. 2001
  • Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-α-deficient mice.  193:1227-1238. 2001
  • The long isoform of terminal deoxynucleotidyl transferase enters the nucleus and, rather than catalyzing nontemplated nucleotide addition, modulates the catalytic activity of the short isoform.  193:89-99. 2001
  • Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells.  191:1789-1797. 2000
  • In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.  190:1417-1425. 1999
  • Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.  189:1545-1554. 1999
  • Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.  189:1169-1179. 1999
  • C-reactive protein: A physiological activator of interleukin 6 receptor shedding.  189:599-604. 1999
  • Viral immune evasion due to persistence of activated T cells without effector function.  188:2205-2213. 1998
  • Assembly of productive T cell receptor δ variable region genes exhibits allelic inclusion.  188:1465-1471. 1998
  • Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection.  188:71-82. 1998
  • B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion.  187:1009-1018. 1998
  • CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease..  187:855-864. 1998
  • CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease.  187:855-864. 1998
  • Antigen is required for the activation of effector activities, whereas interleukin 2 is required for the maintenance of memory in ovalbumin- specific, CD8+ cytotoxic T lymphocytes.  187:49-57. 1998
  • Distinct roles of lymphotoxin α and the type i tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non- bone marrow-derived cells.  186:1997-2004. 1997
  • Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis.  186:1201-1212. 1997
  • Lymphotoxin-α (LTα) supports development of splenic follicular structure that is required for IgG responses.  185:2111-2120. 1997
  • Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity.  185:1203-1210. 1997
  • The association between α4-integrin, P-selectin, and E-selectin in an allergic model of inflammation.  185:1077-1087. 1997
  • Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake.  184:1179-1184. 1996
  • Selectins and neutrophil traffic: Margination and Streptococcus pneumoniae-induced emigration in murine lungs.  184:639-645. 1996
  • Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice.  183:2329-2336. 1996
  • Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells.  183:1879-1892. 1996
  • Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene.  183:1427-1436. 1996
  • gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses..  183:1929-1935. 1996
  • γ/δ T cell-deficient mice have impaired mucosal immunoglobulin a responses.  183:1929-1935. 1996
  • Absence of trauma-induced leukocyte rolling in mice deficient in both P-selectin and intercellular adhesion molecule 1.  183:57-65. 1996
  • Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors.  182:973-982. 1995
  • Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice.  182:129-137. 1995
  • H-2M3a violates the paradigm for major histoeompatibility complex class I peptide binding.  181:1817-1825. 1995
  • The intracellular signal transduction mechanism of interleukin 5 in eosinophils: The involvement of lyn tyrosine kinase and the ras-raf-1-MEK-microtubule-associated protein kinase pathway.  181:1827-1834. 1995
  • Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in streptococcus pneumoniae.  181:973-983. 1995
  • Sequential contribution of l-and p-selectin to leukocyte rolling in vivo.  181:669-675. 1995
  • Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille calmette-guárin vaccines expressing pneumococcal surface protein A.  180:2277-2286. 1994
  • Heterogeneity of single cell cytokine gene expression in clonal T cell populations.  180:1251-1262. 1994
  • Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa.  180:1541-1546. 1994
  • Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology.  179:1551-1561. 1994
  • Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: Auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of VλIIlb.  179:1445-1456. 1994
  • Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors.  179:733-738. 1994
  • Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera.  179:155-165. 1994
  • Helper t cell subsets for immunoglobulin a responses: Oral inmaunization with tetanus toxoid and cholera toxinn as adjuvant selectively induces th2 cells in mucosa associated tissues.  178:1309-1320. 1993
  • Autoinnnune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene.  178:461-468. 1993
  • Localization of a site on bacterial superantigens that determines T cell receptor β chain specificity.  177:283-293. 1993
  • Defective maintenance of T cell tolerance to a superantigen in MRL-lpr/lpr mice.  176:1063-1072. 1992
  • Major histocompatibility complex-restricted recognition of retroviral superantigens by Vβ17+ T cells.  176:275-280. 1992
  • Continuous anti-interleukin 10 antibody administration depletes mice of ly-1 b cells but not conventional b cells.  175:1213-1220. 1992
  • Immunoregulatory functions for murine htraepithelial lymphocytes: γ/δ T cell receptor-positive (TCR+) T cells abrogate oral tolerance, while α/β TCR+ T cells provide B cell help.  175:695-707. 1992
  • Surface proteins from helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.  175:517-525. 1992
  • The human fetal omentum: A site of B cell generation.  175:397-404. 1992
  • Regulated expression of mouse mammary tumor proviral genes in cells of the b lineage.  174:1439-1450. 1991
  • Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci.  174:1255-1258. 1991
  • The salmonella typhlmurium locus mv/a regulates virulence in itys but not ityr mice: Functional mv/a results in avirulence; mutant (nonfunctional) mv/a results in virulence.  174:1073-1083. 1991
  • Specialized functions of major histocompatibility complex class i molecules. ii. hmt binds n-formylated peptides of mitochondrial and prokaryotic origin.  174:941-944. 1991
  • Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells..  173:755-758. 1991
  • Differential tumor necrosis factor α expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains.  173:801-811. 1991
  • Dissociation of the Stimulatory Activities of Staphylococcal Enterotoxins for T Cells and Monocytes.  172:1831-1841. 1990
  • Transgenic Rearranged T Cell Receptor Gene Inhibits Lymphadenopathy and Accumulation of CD4-CD8- B220 + T Cells in lpr/lpr Mice.  172:1805-1817. 1990
  • Coding sequences of the ral-1 gene are disrupted by chromosome translocation in human T cell leukemia.  172:1403-1408. 1990
  • The glycosyl phosphatidylinositol-linked fcγRIIIPMN mediates transmembrane signaling events distinct from FCγRII.  171:1239-1255. 1990
  • Specialized functions of MHC class i molecules: I. An n-formyl peptide receptor is required for construction of the class i antigen Mta.  171:897-912. 1990
  • Identical peptides recognized by MHC class I- and II-restricted T cells.  170:279-289. 1989
  • Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.  169:2133-2148. 1989
  • Reconstruction of the immunogenic peptide RNase (43-56) by identification and transfer of the critical residues into an unrelated peptide backbone.  170:203-215. 1989
  • Identification of distinct C3B and C4B recognition sites in the human C3B/C4B receptor (Cri, Cd35) by deletion mutagenesis.  168:1699-1717. 1988
  • Structure and specificity of T cell receptor γ/δ on major histocompatibility complex antigen-specific CD3+, CD4, CD8 T lymphocytes.  168:1899-1916. 1988
  • T cell receptor gene usage in the response to γ repressor cI protein: An apparent bias in the usage of a Vα gene element.  168:1081-1097. 1988
  • Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.  167:1271-1280. 1988
  • Structure of the human B lymphocyte receptor for C3d and the epstein-barr virus and relatedness to other members of the family of C3/C4 binding proteins.  167:1047-1066. 1988
  • Suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytes.  166:404-418. 1987
  • Human C3B/C4B receptor (CR1): Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3/C4 binding proteins.  165:1095-1112. 1987
  • Maternally transmitted antigens are codominantly expressed by mouse cells containing two kinds of mitochondrial DNA.  165:560-565. 1987
  • Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein a (PspA).  165:381-394. 1987
  • Idiotypic network connectivity and a possible cause of myasthenia gravis.  164:1310-1318. 1986
  • VH Gene expression is restricted in anti-igG antibodies from MRL autoimmune mice.  164:1284-1300. 1986
  • Bystander help in primary immune responses in vivo.  164:814-854. 1986
  • The T cell repertoire for recognition of a phylogenetically distant protein antigen: Peptide specificity and mhc restriction of staphylococcal nuclease-specific T cell clones.  164:897-910. 1986
  • Blockade of clearance of immune complexes by an anti-fcγ receptor monoclonal antibody.  164:474-489. 1986
  • Oncogene expression in autoimmune and normal peripheral blood mononuclear cells.  163:1292-1307. 1986
  • Major histocompatibility complex restriction fragment length polymorphisms define three diabetogenic haplotypes in bb and bbn rats.  162:444-458. 1985
  • Isotype-specific immunoregulation: IgA-binding factors produced by Fcα receptor-positive T cell hybridomas regulate IgA responses.  161:731-747. 1985
  • Regulatory mechanisms in immune responses to heterologous insulins: II. Suppressor T cell activation associated with nonresponsiveness in H-2 b Mice.  160:1012-1026. 1984
  • Preferential induction of polyclonal IgA secretion by murine peyer’s patch dendritic cell-T cell mixtures.  160:941-946. 1984
  • Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus Pneumoniae.  160:386-397. 1984
  • Isotype specificity of helper T cell clones peyer’s patch Th cells preferentially collaborate with mature IgA B cells for IgA responses.  159:798-811. 1984
  • Multiple vh gene segments encode murine antistreptococcal antibodies.  159:179-192. 1984
  • Antigen-specific suppressor T cell interactions: II. Characterization of two different types of suppressor T cell factors specific for L-glutamic acid50-L-Tyrosine50 (GT) and L-glutamic acid60-L-Alanine30-L-Tyrosine10 (GAT).  158:1962-1978. 1983
  • Fine idiotype analysis of b cell precursors in the t-dependent and t-independent responses to αl→3 dextran in balb/c mice.  158:2081-2094. 1983
  • Ultrastructural studies of human lymphoid cells: µ and J chain expression as a function of B cell differentiation.  158:1993-2006. 1983
  • Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation.  158:781-794. 1983
  • Unbalanced x chromosome mosaicism in B cells of mice with X-linked immunodeficiency.  158:920-931. 1983
  • T and B cells that recognize the same antigen do not transcribe similar heavy chain variable region gene segments.  158:192-209. 1983
  • Three T cell hybridomas do not contain detectable heavy chain variable gene transcripts.  158:210-227. 1983
  • Differences in maternal lineages of new zealand black mice defined by restriction endonuclease analysis of mitochondrial dna and by expression of maternally transmitted antigen.  157:2154-2159. 1983
  • Accessory cells in Murine Peyer’s patch: I. Identification and enrichment of a functional dendritic cell.  157:1646-1659. 1983
  • Impaired Fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults.  157:1698-1703. 1983
  • Evidence for a mature B cell subpopulation in peyer’s patches of young adult xid mice.  157:789-794. 1983
  • In vitro regulation of IgA subclass synthesis: I. Discordance between plasma cell production and antibody secretion.  156:1615-1621. 1982
  • Primary cell-mediated lympholysis response to a maternally transmitted antigen.  156:1866-1871. 1982
  • Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus Pneumoniae.  156:1177-1185. 1982
  • Immunoglobulin VH determinants defined by monoclonal antibodies.  156:1010-1024. 1982
  • Murine peyer’s patch T cell clones: Characterization of antigen-specific helper T cells for immunoglobulin a responses.  156:1115-1130. 1982
  • Lack of oral tolerance in C3H/HeJ mice.  155:605-610. 1982
  • Antigen presentation to human t lymphocytes: I. different requirements for stimulation by hapten-modified cells vs. cell sonicates.  154:1005-1015. 1981
  • Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae.  153:694-705. 1981
  • Cross-reactivity between C-reactive protein and idiotypic determinants on a phosphocholine-binding murine myeloma protein.  153:1604-1614. 1981
  • Role of serum IgA. Hepatobiliary transport of circulating antigen.  153:968-976. 1981
  • Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens.  152:1424-1429. 1980
  • Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitro.  152:218-234. 1980
  • Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitro..  152:218s-234s. 1980
  • Clonal nature of the immune response. II. The effect of immunization of clonal commitment.  152:151-160. 1980
  • Murine pancreatic beta-cells express H-2K and H-2D but not Ia antigens..  151:1563-1568. 1980
  • Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency.  151:853-862. 1980
  • Suppression of antibody and T cell proliferative responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by a specific monoclonal T cell factor.  152:235-240. 1980
  • Primary in vitro cytotoxic response of nzb spleen cells to qa-lb-associated antigenic determinants.  150:1555-1560. 1979
  • Presence of plasma cells binding autologous antibody during an immune response.  150:1265-1270. 1979
  • Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect*.  149:993-998. 1979
  • T-cell regulation of murine IgA synthesis.  149:632-643. 1979
  • Regulatory mechanisms in cell-mediated immune responses: VII. Presence of I-C subregion determinants on mixed leukocyte reaction suppressor factor*.  149:114-126. 1979
  • Antigen-specific suppressor T-cell activity in genetically restricted immune spleen cells*.  148:1271-1281. 1978
  • Suppressor T-cell activity in responder × nonresponder (C57BL/10 × DBA/1)F1 spleen cells responsive to L-glutamic acid60-L-alaninea30-L-tyrosine10*.  148:1282-1291. 1978
  • Human immune responses to hapten-conjugated cells: I. Primary and secondary proliferative responses in vitro*.  147:1671-1683. 1978
  • Secretory component on epithelial cells is a surface receptor for polymeric immunoglobulins*.  147:1832-1837. 1978
  • Immunosuppressive factors from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine 10: IV. Lack of strain restrictions among allogeneic, nonresponder donors and recipients*.  147:997-1006. 1978
  • Antigen-specific T-cell-mediated suppression: I. Induction of L-glutamic acide60-L-alanine30-L-tyrosinel10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen*.  147:123-136. 1978
  • Secondary antibody responses in vitro to lglutamic acids60-L-alanine30-L-tyrosine10 (GAT) by (responder × nonresponder)F1 spleen cells stimulated by parental GAT-macrophages*.  146:1827-1832. 1977
  • Regulatory mechanisms in cell-mediated immune responses: VI. Interaction of H-2 and Non-H-2 genes in elaboration of mixed leukocyte reaction suppressor factor*.  146:1221-1233. 1977
  • Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT): III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells*.  146:970-985. 1977
  • Regulatory mechanisms in cell-mediated immune responses: V. H-2 homology requirements for the production of a minor locus-induced suppressor factor*.  146:1152-1157. 1977
  • Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice*.  146:297-301. 1977
  • Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT).  145:839-856. 1977
  • Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic: Acid60-L-alanine30-L-tyrosine10 (GAT) II. Cellular source and effect on responder and nonresponder mice*.  145:828-838. 1977
  • Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines*.  145:760-765. 1977
  • Histocompatibility antigens controlled by the I region of the murine H-2 complex: II. KID Region compatibility is not required for I-region cell-mediated lymphocytotoxicity*.  145:450-454. 1977
  • Regulatory mechanisms in cell-mediated immune responses: IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes*.  144:1214-1226. 1976
  • Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro*.  144:371-381. 1976
  • Histocompatibility antigens controlled by the I region of the murine H-2 complex*: I. Mapping of H-2A and H-2C loci.  143:1439-1452. 1976
  • Regulatory mechanisms in cell-mediated immune responses: III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions*.  143:672-677. 1976
  • Regulatory mechanisms in cell mediated immune responses. II. A genetically restricted suppressor of mixed lymphocyte reactions released by alloantigen activated spleen cells.  142:1391-1402. 1975
  • C1 fixation and classical complement pathway activation by a fragment of the Cμ4 domain of IgM.  142:1322-1326. 1975
  • Clonal dominance. I. Restricted nature of the IgM antibody response to group A streptococcal carbohydrate in mice.  141:1291-1307. 1975
  • Genetic control of immune responses in vitro. VI. Experimental conditions for the development of helper T cell activity specific for the terpolymer L glutamic acid60 L alanine30 L tyrosine10 (GAT) in nonresponder mice.  142:50-60. 1975
  • Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L glutamic acid50 L tyrosine50 (GT) in nonresponder BALB/c mice.  142:1436-1446. 1975
  • Genetic control of specific immune suppression. II. H-2 linked dominant genetic control of immune suppression by the random copolymer L glutamic acid50 L tyrosine50 (GT).  142:1447-1454. 1975
  • Induction of resistance to antibody mediated cytotoxicity. H-2, Ia and Ig antigens are independent entities in the membrane of mouse lymphocytes.  141:1047-1056. 1975
  • Molecular relationship between private and public H 2 antigens as determined by antigen redistribution method.  142:288-298. 1975
  • Regulatory mechanisms in cell-mediated immune responses: I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes.  140:1588-1603. 1974
  • Idiotypic uniformity of cell surface immunoglobulin in chronic lymphocytic leukemia: Evidence for monoclonal proliferation.  140:1416-1420. 1974
  • Immune responses in vitro: XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitco by alloantisera against leukocyte alloantigens.  140:921-938. 1974
  • Serological distinction of mutants B6.C-H(z1) ans B6.M505 from strain C57BL/6.  140:1127-1132. 1974
  • Genetic control of immune responses in vitro: V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer l-glutamic acid60-l-alanine30-l-tyrosine 10 (GAT).  140:648-659. 1974
  • Genetic control of immune responses in vitro: III. tolerogenic properties of the terpolymer l-glutamic acids60-lalanine30- l-tyrosine10 (GAT) for spleen cells from nonresponder (H-28 And H-2q) mice.  140:172-184. 1974
  • Genetic control of immune responses in vitro: IV. conditions for cooperative interactions between nonresponder parental b cells and primed (responder × nonresponder) f1 T cells in the development of an antibody response under Ir gene control in vitro.  140:185-198. 1974
  • Genetic control of immune responses in vitro: I. development of primary and secondary plaque-forming cell responses to the random terpolymer l-glutamic acid60-l-alanine30-l-tyrosine10 (gat) by mouse spleen cells in vitro.  138:1107-1120. 1973
  • Genetic control of immune responses in vitro: II. cellular requirements for the development of primary plaqueforming cell responses to the random terpolymer l-glutamic acid60-l-alanine30-l-tyrosin1e10 (gat)BY mouse spleen cells in vitro.  138:1121-1132. 1973
  • Biological expressions of lymphocyte activation: II. generation of a population of thymus-derived suppressor lymphocytes.  137:649-659. 1973
  • Biological expressions of lymphocyte activation: I. Effects of phytomitogens on antibody synthesis in vitro.  137:205-223. 1973